T1	Participants 39 71	patients with serious infections
T2	Participants 403 415	123 patients
T3	Participants 465 567	atients were considered in whom treatment with the aminoglycoside was not stopped within 72 h (n = 67)
T4	Participants 594 699	patients receiving aminoglycosides for more than 48 h and not using other nephrotoxic medication (n = 85)
